(TheNewswire)
Toronto, Ontario – The Newswire –August 25, 2023 - Ventripoint Diagnostics Ltd.(" Ventripoint " or the " Company "), (TSXV:VPT ) ( OTC:VPTDF) ispleased to announce that it will release its second-quarter financialresults for 2023 on Tuesday, August 29, 2023, after close of market. Ventripoint will host a webinar/conference call at 11:00 a.m. (EST)on Wednesday, September 6, 2023, to discuss its Q2 2023 financialresults and to provide an update on sales and marketing activities. Details of the webinar/conference call are as follows:
PARTICIPANT TELEPHONENUMBERS | ||
ParticipantLink: https://www.c-meeting.com/web3/joinTo/3WYDHYDEHKKUTR/-Ex5Yhj0J28VjV9fPfIbZw | ||
Alternatively, ifparticipant does not have Internet, please call: | ||
Canada/US Toll Free:1-844-763-8274 | ||
International Toll:+1-647-484-8814 | ||
Please dial in 5 – 10 minutes prior to the scheduledstart time and simply ask to join the call.
About Ventripoint DiagnosticsLtd.
Ventripoint has become anindustry leader in the application of AI (Artificial Intelligence) toechocardiography. Ventripoint's VMS products are powered by itsproprietary KBR technology, which is the result of a decade ofdevelopment and provides accurate volumetric cardiac measurementsequivalent to MRI. This affordable, gold-standard alternative allowscardiologists greater confidence in the management of their patients.Providing better care to patients serves as a springboard and basicstandard for all of Ventripoint's products that guide our futuredevelopments. In addition, VMS+ is versatile and can be used with allultrasound systems from any vendor supported by regulatory marketapprovals in the U.S., Europe and Canada. Learn more: www.ventripoint.com.
For further information, pleasecontact:
Jonathan Robinson CFA
(416) 669-1001
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Copyright (c) 2023 TheNewswire - All rights reserved.